Quidel gains CE mark for combined COVID-19, flu and RSV diagnostic test
Company’s molecular testing platform and first assay panel can now be marketed in the EU
Read More
Tag: CE mark
EU approval for new AI technology that can predict heart attacks
CaRi-Heart technology can identify people at high risk of a fatal heart attack
Read More
- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
